Skip to main content
. 2020 Apr 11;17(8):2620. doi: 10.3390/ijerph17082620
ACACA acetyl-CoA carboxylase alpha
ACC acetyl-CoA carboxylase
AFP alpha-fetoprotein
ALIOS American lifestyle-induced obesity syndrome
ALP alkaline phosphatase
ALT alanine aminotransferase
AMPK AMP-activated protein kinase
AOX fatty acyl-CoA oxidase
AR androgen receptor
AR −/ y AR knockout male mice
ARE androgen response element
AREG amphiregulin
ARKO AR konockout
ArKO aromatase-knockout
AST aspartate aminotransferase
ATP5J ATPase coupling factor 6
BDL bile duct ligation
CCA cholangiocarcinoma
CCRKs cell cycle-related kinases
CLD chronic liver disease
CTCs circulating tumor cells
CTGF connective tissue growth factor
DEN diethylnitrosamine
DGAT1/2 diacylglycerol O-acyltransferase 1/2
DHT dihydrotestosterone
DPN bis-hydroxy-phenyl-propionitryle
E2 estradiol
EGF-R epidermal growth factor receptor
ER estrogen receptor
ERα/ERβ estrogen receptor alpha/estrogen receptor beta
ERαKO/ERβKO ERα knockout/ERβ knockout
ESRRG estrogen-related receptor gamma
FA fatty acid
FASN fatty acid synthase
Foxa forkhead box protein A
GGT γ-glutamyltransferase
GLUT glucose transporter
GLR glucagon receptor
GPER G protein-coupled estrogen receptor, known as Gpr30
Gpr30 orphan G protein-coupled receptor 30
H-AR−/y hepatic AR knockout male mice
H-AR−/− hepatic AR knockout female mice
HBsAg HBV surface antigen
HBV hepatitis B
HBx HBV X protein
HCC hepatocellular carcinoma
HCV hepatitis C
HDL-C high-density lipoprotein
HepG2 human liver cell line
HFD high-fat diet
HFHC high-fat and high-cholesterol diet
HRT hormone replacement therapy
IBDM intrahepatic bile duct mass
IFN-γ interferon γ
IL-1β interleukin 1β
IL-6 interleukin 6
IL-12A interleukin 12A
JNK c-Jun N-terminal kinase
KCNN4 Ca2+-activated K+ channel
L-AR−/y liver AR knockout male mice
LDL-C low-density lipoprotein
LKO liver ERα-knockout
lncRNA long non-coding RNAs
LT lymphotoxin
MetS metabolic syndrome
miR microRNA
MMP9 matrix metalloproteinase 9
MOER ERα at the plasma membrane
MTA1 metastasis-associated protein 1
MyD88 myeloid differentiation primary response 88
NAFLD non-alcoholic fatty liver disease
NASH non-alcoholic steatohepatitis
NF-Κb nuclear factor kappa B
NK natural killer
ORX orchidectomized
OVX ovariectomized
PBC primary biliary cirrhosis
PCLD polycystic liver disease
PCOS polycystic ovary syndrome
PEPCK phosphoenolpyruvate carboxykinase
PI3K phosphoinositide 3-kinase
PPAR-α proliferator-activated receptor-alpha
PPAR-δ peroxisome proliferation activator receptor-delta
PPAR-γ peroxisome proliferator activator receptor-gamma
PPT propyl-pyrazole-triol or trisphenol
PR progesterone receptor
PSC primary sclerosing cholangitis
PTP1B protein-tyrosine phosphatase 1B
SCD1 stearoyl-CoA desaturase-1
SGLT Na+-coupled glucose transporters
siRNA small interfering RNA
SREBP-1c sterol-regulatory element-binding protein 1c
STAT3 signal transducer and activator of transcription 3
T testosterone
T2D type 2 diabetes
TCF T cell factor
Tfm testicular feminized male mice
TG triglycerides
TGF-β1 transforming growth factor beta 1
TNFα tumor necrosis factor alpha
vER variant estrogen receptor
VLACS very long fatty acyl-CoA synthetase
WT wild type
wtER wild type estrogen receptor
XIAP X-linked inhibitor of apoptosis protein
5αR 5α-reductase
5αR1/5αR2 5α-reductase type1/5α-reductase type 2
5αR1−/−/5αR2−/− 5α-reductase type1/5α-reductase type 2 knockout